Geert Mannens

2.8k citations

59 papers · 2.1k indexed · h-index 25

Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism 20
Psychiatry and Mental health top 5%
- Schizophrenia research and treatment 4
Pharmaceutical Science top 2%
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 20
Oncology top 5%
- Drug Transport and Resistance Mechanisms 6
- Cancer Treatment and Pharmacology 4
Biochemistry
- Amino Acid Enzymes and Metabolism 4
Molecular Biology
- Enzyme Catalysis and Immobilization 4
Infectious Diseases
- HIV/AIDS drug development and treatment 4
Materials Chemistry
- Enzyme Structure and Function 4

Co-authors: W. Meuldermans Jan Hendrickx J Heykants Filip Cuyckens Pieter Annaert Robert Woestenborghs Minxue Huang Hilde Bohets
Cited by: Pharmacology Psychiatry and Mental health Pharmaceutical Science
Journals: Drug Metabolism and Disposition (12 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Biochemical Pharmacology (3 papers)
Partner nations: Belgium United States United Kingdom

In The Last Decade

Geert Mannens

57 papers receiving 2.0k citations

Peers

Countries citing papers authored by Geert Mannens

Since Specialization

Citations

This map shows the geographic impact of Geert Mannens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Mannens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Mannens more than expected).

Fields of papers citing papers by Geert Mannens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Mannens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Mannens. The network helps show where Geert Mannens may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Geert Mannens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Geert Mannens Line = papers co-authored together Geert Mannens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of 14C-CD388 in the rat Drug Metabolism and Disposition ·Annouschka Laenen,NASEER-UD- DIN,Grayson Hough,Jan Snoeys,Filip Cuyckens,Geert Mannens,Stephen Harris,Voon Ong	2025	0
2	Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro–In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound European Journal of Drug Metabolism and Pharmacokinetics ·Huybrecht T’jollyn,Jan Snoeys,Jan Van Bocxlaer,William S. Chemaly,Pieter Annaert,Achiel Van Peer,Karel Allegaert,Geert Mannens,An Vermeulen,Koen Boussery	2016	5
3	In Vivo Visualization and Quantification of (Disturbed) Oatp-Mediated Hepatic Uptake and Mrp2-Mediated Biliary Excretion of ^99mTc-Mebrofenin in Mice Journal of Nuclear Medicine ·Sara Neyt,Maarten T. Huisman,Christian Vanhove,Byung Yoon Kim,PJ Kilner,Chuntang Chen,M Kinoshita,Geert Mannens,Filip De Vos	2013	27
4	A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects Xenobiotica ·Milin Acharya,Martha Gonzalez,Geert Mannens,Ronald P. de Vries,Christian Lopez,Thomas A. Griffin,NamPhuong Tran	2012	53
5	Evaluation of Three State-of-the-Art Metabolite Prediction Software Packages (Meteor, MetaSite, and StarDrop) through Independent and Synergistic Use Drug Metabolism and Disposition ·Kwon-Hee Park,Koen Boussery,Russell J. Mortishire‐Smith,y Eutse,Benoît De Boeck,Jan F. Van Bocxlaer,Geert Mannens	2011	31
6	Clinical Pharmacology of Alcaftadine, a Novel Antihistamine for the Prevention of Allergic Conjunctivitis Journal of Ocular Pharmacology and Therapeutics ·Hilde Bohets,Claude McGowan,Geert Mannens,Mouhamed Bakel,Gopu S. Varadarajan,Nanda Lailatul Humairoh	2011	23
7	Absorption, Metabolism, and Excretion of Darunavir, a New Protease Inhibitor, Administered Alone and with Low-Dose Ritonavir in Healthy Subjects Drug Metabolism and Disposition ·Marc Vermeir,Sophie Lachau‐Durand,Geert Mannens,Filip Cuyckens,Maren Birkeland,Araz Raoof	2009	59
8	In vitro studies on the metabolism of trabectedin (YONDELIS®) in monkey and man, including human CYP reaction phenotyping Biochemical Pharmacology ·Marc Vermeir,Alex Hemeryck,Filip Cuyckens,Andrés Francesch,Dorothy Law,Jos Van Houdt,W Schirgel,Geert Mannens,Pablo Avilés,R. De Coster	2009	18
9	Absorption, Metabolism, and Excretion of Paliperidone, a New Monoaminergic Antagonist, in Humans Drug Metabolism and Disposition ·Marc Vermeir,Jessica S. Rumschlag,Bart Remmerie,Geert Mannens,Jan Hendrickx,Patrick Sterkens,Krishna Talluri,Sandra Boom,Mariëlle Eerdekens,Nancy Van Osselaer,Adriaan Cleton	2008	133
10	Metabolism and Excretion of RWJ-333369 [1,2-Ethanediol, 1-(2-Chlorophenyl)-, 2-carbamate, (S)-] in Mice, Rats, Rabbits, and Dogs Drug Metabolism and Disposition ·Rao N. V. S. Mamidi,Geert Mannens,Pieter Annaert,Jan Hendrickx,Sang Young Bae Sang Young Bae,Mark Bockx,Andrew Howard,Mark Kao,Michael F. Kelley,W. Meuldermans	2007	12
11	The Absorption, Metabolism, and Excretion of the Novel Neuromodulator RWJ-333369 (1,2-Ethanediol, [1-2-Chlorophenyl]-, 2-carbamate, [ S ]-) in Humans Drug Metabolism and Disposition ·Geert Mannens,Jan Hendrickx,Caballo Reservoir,Shuchean Chien,Maren Birkeland,Tom Verhaeghe,Mark Kao,Michael F. Kelley,Sang Young Bae Sang Young Bae,Mark Bockx,Minjeong Jang,Meir Bialer,W. Meuldermans	2006	35
12	EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES Drug Metabolism and Disposition ·Dirk Roymans,Pieter Annaert,Jos Van Houdt,Christina Jauernik,Cristina Vittoria A. Maraboli,Carlo Sensenhauser,José Silva,Ishibashi Hideto,Jan Hendrickx,Geert Mannens,W. Meuldermans	2005	56
13	In vitro study on transepithelial transport of the psychotropic compound paliperidone (PAL) across Caco-2 monolayers Drug Metabolism Reviews ·Pieter Annaert,W Schirgel,Geert Mannens,Gabriela Puentes Suárez,Sandra Boom,Patrick Sterkens,W. Meuldermans	2005	3
14	4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™ Bioorganic & Medicinal Chemistry Letters ·Patrick Angibaud,Ashis Saha,XingZhi Wang,David W. End,Eddy Freyne,B Raju Naik,Geert Mannens,Laurence Mévellec,Christophe Meyer,M Aslam Alam,吴贵富,Bruno Roux,G. Smets,Jacky Van Dun,Marc Venet,Walter Wouters	2003	13
15	Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes Biochemical Pharmacology ·Dirk Roymans,Ishibashi Hideto,Angelique M. Leone,J. Brandon Parker,Michael McMillian,Mark D. Johnson,Aruna Koganti,Ron Gilissen,Paul M. Silber,Geert Mannens,W. Meuldermans	2003	57
16	Location of the hydroxyl functions in hydroxylated metabolites of nebivolol in different animal species and human subjects as determined by on-line high-performance liquid chromatography-diode-array detection Journal of Chromatography A ·Jan Hendrickx,Dorothy Law,Konrad Martins,Chaoping Yang,Geert Mannens,W. Meuldermans,J Heykants	1996	13
17	Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin* Clinical Pharmacology & Therapeutics ·Murray P. Ducharme,Richard L. Slaughter,L H Warbasse,Pranatharthi Chandrasekar,Vera Van de Velde,Geert Mannens,李明晏	1995	51
18	Absorption, metabolism, and excretion of risperidone in humans. Drug Metabolism and Disposition ·Geert Mannens,Minxue Huang,W. Meuldermans,Jan Hendrickx,Robert Woestenborghs,J Heykants	1993	225
19	Assay for acetyl-CoA: arylamine N-acetyltransferase by high-performance liquid chromatography applied to serotonin N-acetylation Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Geert Mannens,Guido Slegers,Jun-Kong Cheon	1990	5
20	Enzymatic synthesis of 13 N-labeled γ-amino-butyric acid Journal of Labelled Compounds and Radiopharmaceuticals ·张佰南,Guido Slegers,Geert Mannens,A. Claeys	1986	4

About Geert Mannens

Geert Mannens is a scholar working on Pharmacology, Biochemistry, Pharmaceutical Science, Virology and Small Animals, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (6 papers), Amino Acid Enzymes and Metabolism (4 papers), Enzyme Catalysis and Immobilization (4 papers), HIV/AIDS drug development and treatment (4 papers), Schizophrenia research and treatment (4 papers), Enzyme Structure and Function (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Pharmacology (749 citations), Psychiatry and Mental health (353 citations), Pharmaceutical Science (134 citations), Pharmacology (330 citations) and Oncology (472 citations). Geert Mannens has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include W. Meuldermans, Jan Hendrickx, J Heykants, Filip Cuyckens, Pieter Annaert, Robert Woestenborghs, Minxue Huang, Hilde Bohets, Eric Snoeck and Marc Vermeir. Their work appears in journals such as Drug Metabolism and Disposition, Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology, Enzyme and Microbial Technology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact